Arabic Translation and Validation of the (Overactive Bladder Symptom Score) OABSS

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

235 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-02-01

Study Completion Date

2019-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The English version of the Overactive Bladder Symptom Score (OABSS) questionnaire was translated to Arabic language. The questionnaire was validated by comparing the response to the questionnaire in a patient with Overactive Bladder (OAB) before and after providing treatment with antimuscarinics.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prevalence And Risk Factors of Overactive Bladder Syndrome Among Egyptian Medical Students, and Their Impact On Health-Related Quality Of Life

NCT07044778

Overactive Bladder Syndrome

COMPLETED

Behavioural Therapy With Checklist for Overactive Bladder

NCT03662893

Overactive Bladder

COMPLETED NA

Reproducibility Study of Overactive Bladder Symptom Score [OABSS]

NCT01122550

Overactive Bladder

COMPLETED

Reproducibility Study of OABSS and Its Response to Treatment

NCT02667470

Overactive Bladder

COMPLETED PHASE4

Educating Patients on Management of Overactive Bladder: Written Versus Verbal Instructions

NCT02197533

Overactive Bladder

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Overactive Bladder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Study group

Arabic version of the Overactive Bladder Symptom Score Questionnaire

Intervention Type OTHER

All enrolled patients were asked to complete the Arabic OABSS questionnaire in its final edition before and three months after treatment with Solfinasin 5 mg once daily

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Arabic version of the Overactive Bladder Symptom Score Questionnaire

All enrolled patients were asked to complete the Arabic OABSS questionnaire in its final edition before and three months after treatment with Solfinasin 5 mg once daily

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* More than 20 years
* Had three months history of overactive bladder symptoms (urgency with or without incontinence and associated with frequency and nocturia).

Exclusion Criteria

* Active urinary tract infection.
* Predominant symptoms of urinary stress incontinence;
* Diabetes mellitus;
* Previous abdominal and pelvic (urological or gynecological gastrointestinal) surgery;
* Previous neurological disease.

Minimum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No